Molecular regulation and functional benefits of trophoblast syncytialization in optimizing maternal-fetal nutrient

Qianqian Li1, Yuelin Zhu1, Xin Yu2

  • 1State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China; University of Chinese Academy of Sciences, Beijing, 101408, China.

Placenta
|June 11, 2025
PubMed

The placenta governs maternal-fetal nutrient allocation during pregnancy, primarily mediated by placental villi composed of multinucleated syncytiotrophoblasts (STBs) and mononucleated cytotrophoblasts (CTBs) in humans. STBs are formed through cell fusion of CTBs, a process termed syncytialization. The placental villi are bathed in maternal blood sinus, functioning as a critical unit for bidirectional exchange of nutrients and wastes between the mother and fetus, hormone production, and defense against pathogen infection. Trophoblast fusion is regulated by an intricate network of hormones, growth factors, and cytokines, involving mechanisms such as genetic transcription, endogenous retrovirus-derived signaling, epigenetic regulation via DNA methylation or histone modifications, and post-translational modifications including O-GlcNAcylation and ubiquitination. Emerging evidence highlights STBs as nutrient-sensing hubs that adapt transport capacity to maternal nutrient availability. Recent studies demonstrate the activation of macropinocytosis in STBs via mTOR signaling under conditions of nutritional scarcity, synergizing with the multinucleation process to enhance substrate uptake. Metabolomic analyses reveal remarkable suppression of glycolysis and increased fatty acid oxidation in STBs, while appropriate glucose-acetate metabolism epigenetically guides trophoblast cell fate toward syncytium formation. Consequently, metabolic signalings in trophoblasts constitutes a vital physiological mechanism for balancing maternal-placental-fetal nutrient allocation. The integration of interdisciplinary approaches, including single-cell omics, advanced imaging techniques, and organoid models, holds promise for transformative insights into placental biology and the development of diagnostics and therapies targeting placental insufficiency syndromes affecting maternal and fetal health.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Cleavage and Blastulation01:33

Cleavage and Blastulation

After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
44.8K